126 related articles for article (PubMed ID: 37391028)
21. Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents.
Vallöf D; Kalafateli AL; Jerlhag E
Psychoneuroendocrinology; 2019 May; 103():284-295. PubMed ID: 30771711
[TBL] [Abstract][Full Text] [Related]
22. The glucagon-like peptide-1 receptor agonist, exendin-4, reduces sexual interaction behaviors in a brain site-specific manner in sexually naïve male mice.
Vestlund J; Jerlhag E
Horm Behav; 2020 Aug; 124():104778. PubMed ID: 32450068
[TBL] [Abstract][Full Text] [Related]
23. Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.
Bornebusch AB; Fink-Jensen A; Wörtwein G; Seeley RJ; Thomsen M
eNeuro; 2019; 6(2):. PubMed ID: 31058214
[TBL] [Abstract][Full Text] [Related]
24. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
25. Differences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats.
Sisley S; Smith K; Sandoval DA; Seeley RJ
Peptides; 2014 Aug; 58():1-6. PubMed ID: 24879927
[TBL] [Abstract][Full Text] [Related]
26. PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction.
Sun Z; Tong G; Kim TH; Ma N; Niu G; Cao F; Chen X
Theranostics; 2015; 5(3):240-50. PubMed ID: 25553112
[TBL] [Abstract][Full Text] [Related]
27. Preproglucagon derived peptides and thyrotropin (TSH) secretion in the rat: robust and sustained lowering of blood TSH levels in exendin-4 injected animals.
Malendowicz LK; Nowak KW
Int J Mol Med; 2002 Sep; 10(3):327-31. PubMed ID: 12165809
[TBL] [Abstract][Full Text] [Related]
28. A physiological role of glucagon-like peptide-1 receptors in the central nervous system of Suncus murinus (house musk shrew).
Chan SW; Lin G; Yew DT; Rudd JA
Eur J Pharmacol; 2011 Oct; 668(1-2):340-6. PubMed ID: 21756894
[TBL] [Abstract][Full Text] [Related]
29. Parabrachial Nucleus Contributions to Glucagon-Like Peptide-1 Receptor Agonist-Induced Hypophagia.
Swick JC; Alhadeff AL; Grill HJ; Urrea P; Lee SM; Roh H; Baird JP
Neuropsychopharmacology; 2015 Jul; 40(8):2001-14. PubMed ID: 25703200
[TBL] [Abstract][Full Text] [Related]
30. Prolonged exendin-4 administration stimulates pituitary-adrenocortical axis of normal and streptozotocin-induced diabetic rats.
Malendowicz LK; Neri G; Nussdorfer GG; Nowak KW; Zyterska A; Ziolkowska A
Int J Mol Med; 2003 Oct; 12(4):593-6. PubMed ID: 12964040
[TBL] [Abstract][Full Text] [Related]
31. Effects of prolonged exendin-4 administration on entero-insular axis of normal and streptozotocin-induced diabetic rats.
Malendowicz LK; Macchi C; Nussdorfer GG; Nowak KW; Zyterska A; Ziolkowska A
Int J Mol Med; 2003 Jun; 11(6):763-6. PubMed ID: 12736719
[TBL] [Abstract][Full Text] [Related]
32. The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice.
Egecioglu E; Engel JA; Jerlhag E
PLoS One; 2013; 8(10):e77284. PubMed ID: 24204788
[TBL] [Abstract][Full Text] [Related]
33. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
[TBL] [Abstract][Full Text] [Related]
34. Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis.
Borner T; Workinger JL; Tinsley IC; Fortin SM; Stein LM; Chepurny OG; Holz GG; Wierzba AJ; Gryko D; Nexø E; Shaulson ED; Bamezai A; Da Silva VAR; De Jonghe BC; Hayes MR; Doyle RP
Cell Rep; 2020 Jun; 31(11):107768. PubMed ID: 32553160
[TBL] [Abstract][Full Text] [Related]
35. Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas.
Brom M; Joosten L; Oyen WJ; Gotthardt M; Boerman OC
Contrast Media Mol Imaging; 2012; 7(2):160-6. PubMed ID: 22434628
[TBL] [Abstract][Full Text] [Related]
36. Activation of glucagon-like peptide-1 receptors reduces the acquisition of aggression-like behaviors in male mice.
Vestlund J; Zhang Q; Shevchouk OT; Hovey D; Sebastian L; Westberg L; Jerlhag E
Transl Psychiatry; 2022 Oct; 12(1):445. PubMed ID: 36229445
[TBL] [Abstract][Full Text] [Related]
37. The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice.
Egecioglu E; Engel JA; Jerlhag E
PLoS One; 2013; 8(7):e69010. PubMed ID: 23874851
[TBL] [Abstract][Full Text] [Related]
38. High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.
Mul JD; Begg DP; Barrera JG; Li B; Matter EK; D'Alessio DA; Woods SC; Seeley RJ; Sandoval DA
Am J Physiol Regul Integr Comp Physiol; 2013 Jul; 305(1):R68-77. PubMed ID: 23616105
[TBL] [Abstract][Full Text] [Related]
39. Glucagon-like peptide-1 receptors modulate the binge-like feeding induced by µ-opioid receptor stimulation of the nucleus accumbens in the rat.
Pierce-Messick Z; Pratt WE
Neuroreport; 2020 Dec; 31(18):1283-1288. PubMed ID: 33165198
[TBL] [Abstract][Full Text] [Related]
40. Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist.
Baraboi ED; Smith P; Ferguson AV; Richard D
Am J Physiol Regul Integr Comp Physiol; 2010 Apr; 298(4):R1098-110. PubMed ID: 20106992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]